EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy Meeting Abstract

  

Authors:	Miller, K.; Mulders, P.; Freedland, S. J.; Scher, H.; Shore, N.; Park, E.; Krivoshik, A.; Phung, D.; Modelska, K.; Scardino, P.
Abstract Title:	EMBARK: A phase 3, randomized, efficacy and safety study of enzalutamide plus leuprolide, enzalutamide monotherapy and placebo plus leuprolide in men with high-risk nonmetastatic prostate cancer progressing after definitive therapy
Meeting Title:	41st European Society for Medical Oncology Congress (ESMO)
Journal Title:	Annals of Oncology
Volume:	27
Issue:	Suppl. 6
Meeting Dates:	2016 Oct 7-11
Meeting Location:	Copenhagen, Denmark
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2016-10-01
Start Page:	vi264
Language:	English
ACCESSION:	WOS:000393912500766
DOI:	10.1093/annonc/mdw372.53
PROVIDER:	wos
Notes:	Meeting Abstract: 770TiP -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/109034